Correction to Lancet Rheumatol 2022; 4: e262-73

No authors listed

Published Erratum

No authors listed. Lancet Rheumatol. 2022 Jun.

. 2022 Jun;4(6):e392.

doi: 10.1016/S2665-9913(22)00126-6. Epub 2022 Apr 13.

No abstract available

Erratum for

Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study.
Coates LC, Tillett W, D'Agostino MA, Rahman P, Behrens F, McDearmon-Blondell EL, Bu X, Chen L, Kapoor M, Conaghan PG, Mease P. Coates LC, et al. Lancet Rheumatol. 2022 Apr;4(4):e262-e273. doi: 10.1016/S2665-9913(22)00008-X. Epub 2022 Feb 25. Lancet Rheumatol. 2022. PMID: 38288922